VBI Vaccines, Inc. - Company Profile (NASDAQ:VBIV)

About VBI Vaccines, Inc. -

VBI Vaccines, Inc. - logoVBI Vaccines Inc., formerly SciVac Therapeutics Inc., is a biotechnology company. The Company is engaged in developing various technologies that focus on vaccine protection. It has developed an enveloped virus like particle (eVLP) vaccine platform that allows for the design of enveloped VLP vaccines. It is involved in various projects related to human cytomegalovirus (CMV) and other antigens. It is engaged in developing an experimental CMV vaccine using its eVLP vaccine platform. The vaccine is based on the CMV glycoprotein B antigen and is adjuvanted with aluminum phosphate. The eVLP vaccine technology allows for the expression of envelope glyco-proteins within a lipid-bilayer membrane of a VLP. It is developing a therapeutic vaccine candidate for glioblastoma multiforme (GBM). It is developing a vaccine to prevent respiratory syncytial virus (RSV) infection. It also offers Sci-B-Vac, which is a third-generation hepatitis B vaccine.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: VBIV
  • CUSIP:
Key Metrics:
  • Previous Close: $3.65
  • 50 Day Moving Average: $3.70
  • 200 Day Moving Average: $3.88
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $131.89M
  • Outstanding Shares: 36,133,000
Additional Links:
Companies Related to VBI Vaccines, Inc. -:

Analyst Ratings

Consensus Ratings for VBI Vaccines, Inc. - (NASDAQ:VBIV) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for VBI Vaccines, Inc. - (NASDAQ:VBIV)
Show:
DateFirmActionRatingPrice TargetDetails
7/26/2016Ladenburg ThalmannInitiated CoverageBuyView Rating Details
5/7/2015Noble FinancialInitiated CoverageBuy$7.00View Rating Details
(Data available from 8/27/2014 forward)

Earnings

Earnings History for VBI Vaccines, Inc. - (NASDAQ:VBIV)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for VBI Vaccines, Inc. - (NASDAQ:VBIV)
Current Year EPS Consensus Estimate: $-0.67 EPS

Dividends

Dividend History for VBI Vaccines, Inc. - (NASDAQ:VBIV)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for VBI Vaccines, Inc. - (NASDAQ:VBIV)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/14/2015Perceptive Advisors LlcMajor ShareholderBuy650,000$2.08$1,352,000.00View SEC Filing  
9/30/2013Murray George SmithCFOBuy3,027$1.13$3,420.51View SEC Filing  
8/21/2013Murray George SmithCFOBuy8,973$1.17$10,498.41View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for VBI Vaccines, Inc. - (NASDAQ:VBIV)
DateHeadline
finance.yahoo.com logoAn In-Depth Look at the VBI Vaccines CMV Study (NASDAQ:VBIV)
finance.yahoo.com - August 25 at 8:21 PM
finance.yahoo.com logoVBI Vaccines to Continue Enrolling Participants in the Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate Following Successful Data Safety Monitoring Board Review (NASDAQ:VBIV)
finance.yahoo.com - August 25 at 7:41 AM
thestreet.com logoDoes This Under-the-Radar Company Hold the Key to a Zika Vaccine? (NASDAQ:VBIV)
www.thestreet.com - August 9 at 8:27 PM
seekingalpha.com logoUnderstanding The Zika Virus And Which Companies Are Working To Eliminate The Problem (NASDAQ:VBIV)
seekingalpha.com - July 31 at 7:23 PM
finance.yahoo.com logoCoverage initiated on VBI Vaccines by Ladenburg Thalmann (NASDAQ:VBIV)
finance.yahoo.com - July 26 at 7:41 AM
marketwired.com logoVBI Vaccines Appoints Dr. Francisco Diaz-Mitoma as Chief Medical Officer (NASDAQ:VBIV)
www.marketwired.com - July 25 at 8:17 PM
marketwired.com logoVBI Vaccines Applies its eVLP Platform in the Development of a Novel Vaccine Candidate to Prevent Zika Virus (NASDAQ:VBIV)
www.marketwired.com - July 19 at 9:00 AM
publicnow.com logoResearchers Explore the Mechanisms by Which CMV Infection May Impact Fetal Brain Development (NASDAQ:VBIV)
www.publicnow.com - July 14 at 9:28 AM
finance.yahoo.com logoGetting to Know VBI Vaccines (NASDAQ:VBIV)
finance.yahoo.com - July 13 at 1:04 PM
gurufocus.com logoGetting To Know VBI Vaccines Inc. (VBIV) (NASDAQ:VBIV)
www.gurufocus.com - July 12 at 8:20 PM
finance.yahoo.com logoVBI Vaccines Begins Enrolling Patients in a Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate (NASDAQ:VBIV)
finance.yahoo.com - June 23 at 10:39 AM
finance.yahoo.com logo8:38 am VBI Vaccines closes private placement of ~3.27 mln shares of common stock at ~$4.16/share for total gross proceeds of ~$13.6 mln (NASDAQ:VBIV)
finance.yahoo.com - June 21 at 8:38 AM
finance.yahoo.com logoVBI Vaccines Announces Closing of $13.6 Million Private Placement (NASDAQ:VBIV)
finance.yahoo.com - June 21 at 8:30 AM
publicnow.com logoVBI Vaccines Announces Medulloblastoma Immunotherapy Program (NASDAQ:VBIV)
www.publicnow.com - June 17 at 8:39 AM
finance.yahoo.com logoVBI Vaccines to Present at the Virus-Like Particle and Nano-Particle Vaccines Conference (NASDAQ:VBIV)
finance.yahoo.com - June 17 at 8:30 AM
finance.yahoo.com logoVBI Vaccines to Host Hepatitis B Key Opinion Leader Meeting (NASDAQ:VBIV)
finance.yahoo.com - June 11 at 11:00 AM
marketwired.com logoVBI Vaccines to Present at the BIO International Convention (NASDAQ:VBIV)
www.marketwired.com - June 3 at 8:50 PM
finance.yahoo.com logoVBI Vaccines to Present at the Jefferies Healthcare Conference (NASDAQ:VBIV)
finance.yahoo.com - May 27 at 8:30 AM
biz.yahoo.com logoVBI VACCINES INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Dispos (NASDAQ:VBIV)
biz.yahoo.com - May 9 at 5:14 PM
publicnow.com logoAdditional Details Relating to the SciVac Therapeutics and VBI Vaccines Merger Transaction (NASDAQ:VBIV)
www.publicnow.com - May 9 at 3:28 PM
publicnow.com logoVBI Vaccines to Present at the Bloom Burton Healthcare Investor Conference (NASDAQ:VBIV)
www.publicnow.com - April 28 at 8:54 AM
publicnow.com logoVBI Vaccines and SciVac Therapeutics Announce Effectiveness of Registration Statement on Form F-4 (NASDAQ:VBIV)
www.publicnow.com - April 14 at 8:49 AM
biz.yahoo.com logoVBI VACCINES INC. Files SEC form 8-K, Other Events (NASDAQ:VBIV)
biz.yahoo.com - March 30 at 4:55 PM
publicnow.com logoVBI Vaccines to Present at the World Vaccine Congress Washington (NASDAQ:VBIV)
www.publicnow.com - March 29 at 8:37 AM
investing.com logoVBI Vaccines: Changing The Game In Vaccines (NASDAQ:VBIV)
www.investing.com - February 26 at 2:13 PM
4-traders.com logoVBI Vaccines Inc : 3 Stocks That Should be in Your Portfolio Today (NASDAQ:VBIV)
www.4-traders.com - February 26 at 2:13 PM
biz.yahoo.com logoVBI VACCINES INC. Files SEC form 10-K, Annual Report (NASDAQ:VBIV)
biz.yahoo.com - February 26 at 6:36 AM
finance.yahoo.com logoGlaxoSmithKline Partners With VBI Vaccines, SciVac To Eliminate Cold Chain (NASDAQ:VBIV)
finance.yahoo.com - February 17 at 9:29 AM
finance.yahoo.com logoBiotech Stocks to Buy in a Down Market (NASDAQ:VBIV)
finance.yahoo.com - February 10 at 12:45 PM
biz.yahoo.com logoVBI VACCINES INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial (NASDAQ:VBIV)
biz.yahoo.com - February 9 at 8:33 AM
finance.yahoo.com logoVBI Vaccines Announces Research Collaboration with GlaxoSmithKline to Enhance Vaccine Stability (NASDAQ:VBIV)
finance.yahoo.com - February 9 at 8:30 AM
finance.yahoo.com logoVBI Vaccines Partners with the Canadian CMV Foundation to Raise Congenital Cytomegalovirus Awareness (NASDAQ:VBIV)
finance.yahoo.com - February 4 at 8:30 AM
publicnow.com logoVBI Vaccines to Present at the BIO CEO & Investor Conference (NASDAQ:VBIV)
www.publicnow.com - January 26 at 8:49 AM
noodls.com logoVBI Vaccines to Present at the Noble Financial Emerging Growth Investor Conference (NASDAQ:VBIV)
www.noodls.com - January 18 at 8:42 AM
biz.yahoo.com logoVBI VACCINES INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:VBIV)
biz.yahoo.com - January 15 at 8:33 AM
biz.yahoo.com logoVBI VACCINES INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NASDAQ:VBIV)
biz.yahoo.com - December 22 at 8:33 AM
biz.yahoo.com logoVBI VACCINES INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Of (NASDAQ:VBIV)
biz.yahoo.com - December 11 at 4:06 PM
finance.yahoo.com logoVBI VACCINES INC. Financials (NASDAQ:VBIV)
finance.yahoo.com - December 8 at 1:17 PM
finance.yahoo.com logoINVESTOR ALERT: December's Trending Biotech Stocks (NASDAQ:VBIV)
finance.yahoo.com - December 3 at 12:59 PM
noodls.com logoVBI Vaccines to Present at the LD Micro Conference (NASDAQ:VBIV)
www.noodls.com - November 25 at 8:45 AM
noodls.com logoVBI Vaccines Presents Update and New Data Supporting its Glioblastoma Immunotherapy Program at the ESMO Symposium on Immuno-Oncology (NASDAQ:VBIV)
www.noodls.com - November 20 at 8:46 AM
biz.yahoo.com logoVBI VACCINES INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:VBIV)
biz.yahoo.com - November 20 at 8:31 AM
noodls.com logoVBI Vaccines to Present Update and New Data Supporting its RSV and CMV Vaccine Programs at the World Vaccine Congress Europe (NASDAQ:VBIV)
www.noodls.com - November 6 at 8:54 AM

Social

VBI Vaccines, Inc. - (NASDAQ:VBIV) Chart for Saturday, August, 27, 2016


Last Updated on 8/27/2016 by MarketBeat.com Staff